Diversified Trust Co Has $869,000 Stock Holdings in Inspire Medical Systems, Inc. (NYSE:INSP)

Diversified Trust Co grew its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 3.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,686 shares of the company’s stock after buying an additional 173 shares during the period. Diversified Trust Co’s holdings in Inspire Medical Systems were worth $869,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. AQR Capital Management LLC grew its stake in Inspire Medical Systems by 152.7% during the second quarter. AQR Capital Management LLC now owns 231,845 shares of the company’s stock worth $31,028,000 after purchasing an additional 140,090 shares during the period. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in Inspire Medical Systems during the third quarter worth approximately $1,929,000. Thrivent Financial for Lutherans grew its stake in Inspire Medical Systems by 39.7% during the third quarter. Thrivent Financial for Lutherans now owns 110,580 shares of the company’s stock worth $23,337,000 after purchasing an additional 31,444 shares during the period. WINTON GROUP Ltd acquired a new stake in Inspire Medical Systems during the second quarter worth approximately $1,084,000. Finally, Scientech Research LLC acquired a new stake in Inspire Medical Systems during the second quarter worth approximately $1,574,000. Institutional investors and hedge funds own 94.91% of the company’s stock.

Analyst Ratings Changes

Several research firms recently commented on INSP. Truist Financial reaffirmed a “buy” rating and set a $240.00 target price (up previously from $217.00) on shares of Inspire Medical Systems in a research note on Monday, September 30th. Bank of America upgraded Inspire Medical Systems from a “neutral” rating to a “buy” rating and increased their price target for the stock from $220.00 to $255.00 in a report on Wednesday, November 20th. Stifel Nicolaus reiterated a “hold” rating and issued a $200.00 price target (up previously from $170.00) on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Royal Bank of Canada reiterated an “outperform” rating and issued a $260.00 price target on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Finally, Wells Fargo & Company increased their price target on Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $233.58.

Inspire Medical Systems Trading Down 0.5 %

Shares of Inspire Medical Systems stock opened at $214.27 on Friday. The business’s fifty day simple moving average is $191.46 and its 200 day simple moving average is $182.92. The firm has a market capitalization of $6.42 billion, a P/E ratio of 200.25 and a beta of 1.32. Inspire Medical Systems, Inc. has a 12 month low of $123.00 and a 12 month high of $257.40.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.60 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.54. The business had revenue of $203.20 million for the quarter, compared to analyst estimates of $197.59 million. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. Inspire Medical Systems’s quarterly revenue was up 32.6% compared to the same quarter last year. During the same period last year, the company posted ($0.29) earnings per share. Analysts predict that Inspire Medical Systems, Inc. will post 1.33 EPS for the current fiscal year.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.